Peter K. Miller

Biography

Peter Miller joined the Board of Directors of OptiNose AS in 2008 when he first became familiar with the Company’s unique approach to nasal drug delivery and convinced of the potential for using it to create clinically important new products. In 2010, in partnership with Ramy Mahmoud, Mr. Miller led the start-up of Optinose in collaboration with Avista Capital Partners, acquiring OptiNose AS and accepting the role of CEO. He also serves as a member of the Board of Directors of Optinose. Mr. Miller was previously the Co-Founder, CEO and President of Take Care Health Systems, a company that disrupted the US healthcare system through a revolutionary idea to operate medical clinics inside Walgreens retail pharmacies. Mr. Miller served as a Vice President in the Walgreens Health and Wellness Division and remained CEO for Take Care Health Systems for three years after its sale to Walgreens while growing the clinical operation to more than 400 clinics nationwide.

Research Interest

Earlier, Mr. Miller spent more than 15 years at Johnson & Johnson, serving in a variety of marketing and general management roles that included Worldwide President of Johnson & Johnson – Merck Consumer Pharmaceuticals and President of Janssen Pharmaceuticals, a $4 billion pharmaceutical company. While at Johnson & Johnson, he played an integral role in building brands such as Tylenol, Motrin, Imodium, Pepcid, Duragesic, Risperdal and Aciphex. Mr. Miller earned an economics degree from Trinity College and an MBA from the Kellogg School of Management at Northwestern University.